Skip to main content

Table 1 Baseline characteristics according to values below median (more negative) (n = 65) or above median (more positive) (n = 52), median GLS (median = −11 %)

From: Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure

Variable

Below median GLS

Above median GLS

p-value

(n = 65)

(n = 52)

Age, years

69 (63–76)

71 (67–76)

0.761

Female gender, %

33.8

21.2

0.130

BMIa, kg/m2

26.0 (22.6-30.2)

26.3 (24.5-30.3)

0.214

NYHAb class III-IV, %

23.1

30.8

0.349

Systolic BPc, mmHg

132 (120–147)

120 (110–140)

0.178

Diastolic BPc, mmHg

77 (70–82)

77 (69–84)

0.889

Heart rate, beats/min

64 (56–76)

70 (62–78)

0.188

HFd duration, months

9 (6–12)

12 (6–24)

0.216

Pervious MIe, %

33.8

44.2

0.251

Hypertension, %

67.7

59.6

0.395

Atrial fibrillation, %

24.6

40.4

0.068

ICDf, %

9.5

13.5

0.507

Diabetes, %

20

25

0.518

ApoplexiaCerebri/TCIg, %

12.3

23.1

0.124

ACE-Ih, %

73.8

59.6

0.140

ARBi, %

21.5

32.7

0.174

Beta-blocker, %

87.7

86.5

0.853

MRAj, %

14.1

28.8

0.051

Diuretics, %

69.2

76.9

0.354

Hemoglobine, mmol/l

8.5 (7.0-9.0)

8.8 (8.0-9.3)

0.215

Creatinine, umol/l

80 (68–97)

95 (73–119)

0.254

eGFRk, ml/min/1,73 m2

82 (66–98)

70 (51–95)

0.244

  1. aBody mass index, bNew York Heart Association, cBlood pressure, dHeart failure, eMyocardial infarction, fImplantable cardiac defibrillator, gTransitory cerebral ischemia, hAngiotensin converting enzyme inhibitor, iAldosterone receptor blocker, jMineralocorticoid receptor antagonist, kEstimated glomerular filtration rate